Início »
Pub »
2018 »
Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil
Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil

Author: Cynthia Batista
Phone: +55 61 3315-7635
email: cynthia.batista@aids.gov.br(link sends e-mail)